Experts detail the benefits of swimming, from strengthening your muscles to reducing inflammation and boosting your mental health—and how to get started. Swimming offers a low-impact exercise with ...

Galapagos (GLPG) announced the topline results from two Phase 3-enabling studies evaluating the efficacy and safety of GLPG3667, a selective TYK2 ...

An investigational monoclonal antibody targeting interferon beta (IFNβ) led to rapid and pronounced reductions in disease activity in adults with dermatomyositis, a randomized phase II study showed.

Matthew Herper covers medical innovation — both its promise and its perils. The biotech firm Roivant and its spinout Priovant said Wednesday that their immune-modifying drug brepocitinib outperformed ...

Commercial autoantibody testing showed no significant differences in the prevalence of myositis-specific and myositis-associated autoantibodies between patients with classic dermatomyositis and those ...

I'm a Fitness & Nutrition writer for CNET who enjoys reviewing the latest fitness gadgets, testing out activewear and sneakers, as well as debunking wellness/fitness myths. In my free time I enjoy ...

Idiopathic inflammatory myopathies (IIMs) are associated with autoantibodies against nuclear and cytoplasmic antigens. Myositis-specific autoantibodies (MSAs) are specific to patients with IIMs.

Dermatomyositis (DM) is a chronic autoimmune disease characterized by inflammatory myopathy and distinctive skin manifestations, significantly affecting patients' quality of life. Dazukibart, a novel ...

Getting back into exercise after illness can be challenging. Tips for returning to exercise after being sick include starting at home, keeping hydrated, and avoiding overexertion. People who want to ...

As we age, maintaining an active lifestyle becomes crucial for long-term health and wellness, but some forms of exercise begin to lose their appeal. Biking outdoors, for example, can be a fun and ...

argenx remains a dominant player in the anti-FcRn market, with Vyvgart approved for gMG, CIDP, and ITP in Japan. The ALKIVIA trial aims to expand Vyvgart's use in myositis, a rare autoimmune disease ...